Citation Impact
Citing Papers
Prediction of Postoperative Pulmonary Complications in a Population-based Surgical Cohort
2010 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
2007 Standout
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Targeting mast cells in inflammatory diseases
2014
Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone?
1993
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
2005 Standout
Do Physical Signs Reflect the Degree of Airflow Obstruction in Patients with Asthma or Chronic Obstructive Pulmonary Disease?
1991
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
2003 Standout
Intra‐session repeatability of FET and FEV6 in the general population
2008
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Nanoparticles in cancer therapy and diagnosis
2002 Standout
Effects of nedocromil sodium (Tilade®) on the activation of human eosinophils and neutrophils and the release of histamine from mast cells
1988
Routine use of oxygen in the treatment of myocardial infarction: systematic review
2008
Relation between FEV1 and peak expiratory flow in patients with chronic airflow obstruction.
1988
Hydrogel nanoparticles in drug delivery
2008 Standout
Why we need large, simple studies of the clinical examination: the problem and a proposed solution
1999
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Prospective Assessment of Cholesterol Embolization in Patients With Acute Myocardial Infarction Treated With Thrombolytic vs Conservative Therapy
1995
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
2009 Standout
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Comparison of Peak Expiratory Flow Rate and FEV1 in Assessing Bronchomotor Tone after Challenges with Occupational Sensitizers
1991
Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis
1994 Standout
Double-blind comparison of nedocromil sodium (1% nasal spray) and placebo in rhinitis caused by birch pollen
1987
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Global burden of liver disease: 2023 update
2023 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Management of Hypertensive Urgencies and Emergencies
1995
Burden and clinical features of chronic obstructive pulmonary disease (COPD)
2004
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed
2010 Standout
Guidelines for Methacholine and Exercise Challenge Testing—1999
2000 Standout
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement
2019 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
The chromones: history, chemistry and clinical development. A tribute to the work of Dr R. E. C. Altounyan
2000
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
Physical−Chemical Aspects of Protein Corona: Relevance toin Vitroandin VivoBiological Impacts of Nanoparticles
2011 Standout
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema
2013
Efficacy and Safety of Nedocromil Sodium Ophthalmic Solution in the Treatment of Seasonal Allergic Conjunctivitis
1992
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Drug delivery and nanoparticles: Applications and hazards
2008 Standout
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
2011 Standout
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 Standout
DOUBLE‐BLIND STUDY OF THE EFFECT OF CARDIOSELECTIVE BETA‐BLOCKADE ON CHEST PAIN IN ACUTE MYOCARDIAL INFARCTION*
1976
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Validation of a Vertical Visual Analogue Scale as a Measure of Clinical Dyspnea
1989
Magnetic nanoparticle design for medical diagnosis and therapy
2004 Standout
Works of S. Lal being referenced
Nedocromil Sodium Is More Effective Than Cromolyn Sodium for the Treatment of Chronic Reversible Obstructive Airway Disease
1993
OXYGEN ADMINISTRATION AFTER MYOCARDIAL INFARCTION
1969
CARDIOVASCULAR AND RESPIRATORY EFFECTS OF MORPHINE AND PENTAZOCINE IN PATIENTS WITH MYOCARDIAL INFARCTION
1969
Mortality of patients with acute myocardial infarction
1973
Nedocromil sodium: a new drug for the management of bronchial asthma.
1984
OXYGEN ADMINISTRATION AFTER MYOCARDIAL INFARCTION
1969
Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
1986
Forced Expiratory Time: A Simple Test for Airways Obstruction
1964
The pharmacokinetics of nedocromil sodium, a new drug for the treatment of reversible obstructive airways disease, in human volunteers and patients with reversible obstructive airways disease.
1987